| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 |
| filingDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018511577-A |
| titleOfInvention |
Method for treatment management of diarrhea-type irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC5856 |
| abstract |
The present invention provides for the treatment of diarrhea-type irritable bowel syndrome in humans, including oral administration in a special manner of Bacillus coagulans SBC37-01, MTCC 5856 (including over 2 billion spores) in addition to standard care care. A method of treatment management is disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021520228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7183301-B2 |
| priorityDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |